| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K61166597 |
| PharmacoGx | BRD-K61166597 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RP11-1012A1.4 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | LRPPRC | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | CHMP3 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | NUTM2E | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ZFP36L1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | C20orf24 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CLK2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | SNX19 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | CLCN4 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CSF1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
